
    
      A multicenter, Prospective, Randomized, Open-label, Phase 4 Trial designed to Evaluate the
      Efficacy of a Fixed Dose Combination of Telmisartan/S-Amlodipine on 24-hour Ambulatory BP
      Control Compared with Telmisartan Monotherapy
    
  